{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:26:46Z","timestamp":1788402406212,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["HL124266"],"award-info":[{"award-number":["HL124266"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018109","name":"Veterans Medical Research Foundation","doi-asserted-by":"publisher","award":["1 I01 CX002684-01"],"award-info":[{"award-number":["1 I01 CX002684-01"]}],"id":[{"id":"10.13039\/100018109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12015-024-10759-7","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:02:04Z","timestamp":1720584124000},"page":"1971-1980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autotaxin Inhibition Reduces Post\u2010Ischemic Myocardial Inflammation via Epigenetic Gene Modifications"],"prefix":"10.1007","volume":"20","author":[{"given":"Landys Z.","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himi","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadea M.","family":"Tarhuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-7102","authenticated-orcid":false,"given":"Ahmed","family":"Abdel-Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"issue":"1","key":"10759_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D., & Frangogiannis, N. G. (2016). The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis. Circulation Research, 119(1), 91\u2013112. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303577","journal-title":"Circulation Research"},{"issue":"5","key":"10759_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","volume":"11","author":"NG Frangogiannis","year":"2014","unstructured":"Frangogiannis, N. G. (2014). The inflammatory response in myocardial injury, repair, and remodelling. Nature Reviews Cardiology, 11(5), 255\u201365. https:\/\/doi.org\/10.1038\/nrcardio.2014.28","journal-title":"Nature Reviews Cardiology"},{"key":"10759_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.yjmcc.2020.09.011","volume":"149","author":"H Tripathi","year":"2020","unstructured":"Tripathi, H., Al-Darraji, A., Abo-Aly, M., Peng, H., Shokri, E., Chelvarajan, L., et al. (2020). Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction. Journal of Molecular and Cellular Cardiology, 149, 95\u2013114. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.09.011","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10759_CR4","doi-asserted-by":"publisher","unstructured":"Tripathi, H., Shindo, K., Donahue, R. R., Gao, E., Kuppa, A., ElKammar, M., et al. (2022). Myeloid-specific deletion of lipid Plpp3 (phosphate phosphatase 3) increases cardiac inflammation after myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology. https:\/\/doi.org\/10.1161\/ATVBAHA.122.317830","DOI":"10.1161\/ATVBAHA.122.317830"},{"issue":"3","key":"10759_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister, A. J., & Kouzarides, T. (2011). Regulation of chromatin by histone modifications. Cell Research, 21(3), 381\u201395. https:\/\/doi.org\/10.1038\/cr.2011.22","journal-title":"Cell Research"},{"key":"10759_CR6","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3389\/fimmu.2019.01525","volume":"10","author":"AEA Surace","year":"2019","unstructured":"Surace, A. E. A., & Hedrich, C. M. (2019). The role of epigenetics in autoimmune\/inflammatory disease. Frontiers in Immunology, 10, 1525. https:\/\/doi.org\/10.3389\/fimmu.2019.01525","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10759_CR7","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1002\/mco2.173","volume":"3","author":"S Zhang","year":"2022","unstructured":"Zhang, S., Meng, Y., Zhou, L., Qiu, L., Wang, H., Su, D., et al. (2022). Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy. MedComm (2020), 3(4), e173. https:\/\/doi.org\/10.1002\/mco2.173","journal-title":"MedComm (2020)"},{"key":"10759_CR8","doi-asserted-by":"publisher","first-page":"780649","DOI":"10.3389\/fgene.2021.780649","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen, J., Liu, Z., Ma, L., Gao, S., Fu, H., Wang, C., et al. (2021). Targeting epigenetics and non-coding RNAs in myocardial infarction: From mechanisms to therapeutics. Frontiers in Genetics, 12, 780649. https:\/\/doi.org\/10.3389\/fgene.2021.780649","journal-title":"Frontiers in Genetics"},{"issue":"3","key":"10759_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cardiores.2007.08.010","volume":"76","author":"TC Zhao","year":"2007","unstructured":"Zhao, T. C., Cheng, G., Zhang, L. X., Tseng, Y. T., & Padbury, J. F. (2007). Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovascular Research, 76(3), 473\u201381. https:\/\/doi.org\/10.1016\/j.cardiores.2007.08.010","journal-title":"Cardiovascular Research"},{"issue":"12","key":"10759_CR10","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","volume":"107","author":"E Gao","year":"2010","unstructured":"Gao, E., Lei, Y. H., Shang, X., Huang, Z. M., Zuo, L., Boucher, M., et al. (2010). A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circulation Research, 107(12), 1445\u20131453. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223925","journal-title":"Circulation Research"},{"issue":"12","key":"10759_CR11","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1590\/1414-431x20154734","volume":"48","author":"CO Beltrame","year":"2015","unstructured":"Beltrame, C. O., C\u00f4rtes, M. F., Bandeira, P. T., & Figueiredo, A. M. (2015). Optimization of the RNeasy Mini Kit to obtain high-quality total RNA from sessile cells of Staphylococcus aureus. Brazilian Journal of Medical and Biological Research, 48(12), 1071\u20136. https:\/\/doi.org\/10.1590\/1414-431x20154734","journal-title":"Brazilian Journal of Medical and Biological Research"},{"issue":"1","key":"10759_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12896-014-0094-8","volume":"14","author":"MK Sellin Jeffries","year":"2014","unstructured":"Sellin Jeffries, M. K., Kiss, A. J., Smith, A. W., & Oris, J. T. (2014). A comparison of commercially-available automated and manual extraction kits for the isolation of total RNA from small tissue samples. BMC Biotechnology., 14(1), 94. https:\/\/doi.org\/10.1186\/s12896-014-0094-8","journal-title":"BMC Biotechnology."},{"issue":"1\u20132","key":"10759_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jviromet.2008.08.007","volume":"154","author":"ST Workenhe","year":"2008","unstructured":"Workenhe, S. T., Kibenge, M. J., Iwamoto, T., & Kibenge, F. S. (2008). Absolute quantitation of infectious salmon anaemia virus using different real-time reverse transcription PCR chemistries. Journal of Virological Methods, 154(1\u20132), 128\u201334. https:\/\/doi.org\/10.1016\/j.jviromet.2008.08.007","journal-title":"Journal of Virological Methods"},{"issue":"5","key":"10759_CR14","doi-asserted-by":"publisher","first-page":"e0127287","DOI":"10.1371\/journal.pone.0127287","volume":"10","author":"DR Boone","year":"2015","unstructured":"Boone, D. R., Micci, M.-A., Taglialatela, I. G., Hellmich, J. L., Weisz, H. A., Bi, M., et al. (2015). Pathway-focused PCR array profiling of enriched populations of laser capture microdissected hippocampal cells after traumatic brain injury. PLoS ONE, 10(5), e0127287. https:\/\/doi.org\/10.1371\/journal.pone.0127287","journal-title":"PLoS ONE"},{"key":"10759_CR15","doi-asserted-by":"publisher","unstructured":"Li, Y., Yang, Y., Xiong, A., Wu, X., Xie, J., Han, S., et al. (2017). Comparative gene expression analysis of lymphocytes treated with exosomes derived from ovarian cancer and ovarian cysts. Frontiers in Immunology, 8(607). https:\/\/doi.org\/10.3389\/fimmu.2017.00607","DOI":"10.3389\/fimmu.2017.00607"},{"issue":"1","key":"10759_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","volume":"20","author":"SA Dick","year":"2019","unstructured":"Dick, S. A., Macklin, J. A., Nejat, S., Momen, A., Clemente-Casares, X., Althagafi, M. G., et al. (2019). Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nature Immunology, 20(1), 29\u201339. https:\/\/doi.org\/10.1038\/s41590-018-0272-2","journal-title":"Nature Immunology"},{"issue":"12","key":"10759_CR17","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1084\/jem.20070885","volume":"204","author":"M Nahrendorf","year":"2007","unstructured":"Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J. L., et al. (2007). The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. The Journal of Experimental Medicine, 204(12), 3037\u201347. https:\/\/doi.org\/10.1084\/jem.20070885","journal-title":"The Journal of Experimental Medicine"},{"issue":"10","key":"10759_CR18","doi-asserted-by":"publisher","first-page":"108472","DOI":"10.1016\/j.celrep.2020.108472","volume":"33","author":"Z Wang","year":"2020","unstructured":"Wang, Z., Cui, M., Shah, A. M., Tan, W., Liu, N., Bassel-Duby, R., et al. (2020). Cell-type-specific gene regulatory networks underlying murine neonatal heart regeneration at single-cell resolution. Cell Reports, 33(10), 108472. https:\/\/doi.org\/10.1016\/j.celrep.2020.108472","journal-title":"Cell Reports"},{"issue":"1","key":"10759_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13023-023-02896-y","volume":"18","author":"C Zhu","year":"2023","unstructured":"Zhu, C., Piao, Z., & Jin, L. (2023). HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction. Orphanet Journal of Rare Diseases, 18(1), 266. https:\/\/doi.org\/10.1186\/s13023-023-02896-y","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"Pt C","key":"10759_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.semcdb.2022.08.005","volume":"154","author":"T Chen","year":"2024","unstructured":"Chen, T., Liu, J., Li, S., Wang, P., & Shang, G. (2024). The role of protein arginine N-methyltransferases in inflammation. Seminars in Cell & Developmental Biology, 154(Pt C), 208\u201314. https:\/\/doi.org\/10.1016\/j.semcdb.2022.08.005","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"4","key":"10759_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41419-022-04719-7","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu, H., Jia, K., Ren, Z., Sun, J., & Pan, L. L. (2022). PRMT5 critically mediates TMAO-induced inflammatory response in vascular smooth muscle cells. Cell Death & Disease, 13(4), 299. https:\/\/doi.org\/10.1038\/s41419-022-04719-7","journal-title":"Cell Death & Disease"},{"issue":"4","key":"10759_CR22","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.4049\/jimmunol.1601702","volume":"198","author":"LM Webb","year":"2017","unstructured":"Webb, L. M., Amici, S. A., Jablonski, K. A., Savardekar, H., Panfil, A. R., Li, L., et al. (2017). PRMT5-selective inhibitors suppress inflammatory T cell responses and experimental autoimmune encephalomyelitis. The Journal of Immunology, 198(4), 1439\u201351. https:\/\/doi.org\/10.4049\/jimmunol.1601702","journal-title":"The Journal of Immunology"},{"issue":"8","key":"10759_CR23","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/jcmm.17676","volume":"27","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Verwilligen, R. A. F., Van Eck, M., & Hoekstra, M. (2023). PRMT5 inhibition induces pro-inflammatory macrophage polarization and increased hepatic triglyceride levels without affecting atherosclerosis in mice. Journal of Cellular and Molecular Medicine, 27(8), 1056\u201368. https:\/\/doi.org\/10.1111\/jcmm.17676","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10759_CR24","doi-asserted-by":"publisher","first-page":"110529","DOI":"10.1016\/j.intimp.2023.110529","volume":"122","author":"X Fei","year":"2023","unstructured":"Fei, X., Cen, X., Zhao, R., Wang, J., & Cui, H. (2023). PRMT5 knockdown enhances cell viability and suppresses cell apoptosis, oxidative stress, inflammation and endothelial dysfunction in ox-LDL-induced vascular endothelial cells via interacting with PDCD4. International Immunopharmacology, 122, 110529. https:\/\/doi.org\/10.1016\/j.intimp.2023.110529","journal-title":"International Immunopharmacology"},{"issue":"1","key":"10759_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.intimp.2014.10.029","volume":"24","author":"N Kang","year":"2015","unstructured":"Kang, N., Chen, P., Chen, Y., Zeng, H., He, X., & Zhu, Y. (2015). PRMT6 mediates CSE induced inflammation and apoptosis. International Immunopharmacology, 24(1), 95\u2013101. https:\/\/doi.org\/10.1016\/j.intimp.2014.10.029","journal-title":"International Immunopharmacology"},{"key":"10759_CR26","doi-asserted-by":"publisher","unstructured":"Liang, Q., Cai, M., Zhang, J., Song, W., Zhu, W., Xi, L., et al. (2020). Role of muscle-specific histone methyltransferase (Smyd1) in exercise-induced cardioprotection against pathological remodeling after myocardial infarction. International Journal of Molecular Sciences, 21(19). https:\/\/doi.org\/10.3390\/ijms21197010","DOI":"10.3390\/ijms21197010"},{"key":"10759_CR27","doi-asserted-by":"publisher","first-page":"654682","DOI":"10.3389\/fcell.2021.654682","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang, Z., Schwartz, R. J., Liu, J., Sun, F., Li, Q., & Ma, Y. (2021). Smyd1 orchestrates early heart development through positive and negative gene regulation. Frontiers in Cell and Developmental Biology, 9, 654682. https:\/\/doi.org\/10.3389\/fcell.2021.654682","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"33","key":"10759_CR28","doi-asserted-by":"publisher","first-page":"E7871","DOI":"10.1073\/pnas.1800680115","volume":"115","author":"JS Warren","year":"2018","unstructured":"Warren, J. S., Tracy, C. M., Miller, M. R., Makaju, A., Szulik, M. W., Oka, S. I., et al. (2018). Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart. Proceedings of the National Academy of Sciences of the United States of America, 115(33), E7871\u2013E80. https:\/\/doi.org\/10.1073\/pnas.1800680115","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10759_CR29","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/bies.20081","volume":"26","author":"WH Moolenaar","year":"2004","unstructured":"Moolenaar, W. H., van Meeteren, L. A., & Giepmans, B. N. (2004). The ins and outs of lysophosphatidic acid signaling. BioEssays, 26(8), 870\u2013881. https:\/\/doi.org\/10.1002\/bies.20081","journal-title":"BioEssays"},{"issue":"2","key":"10759_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.plipres.2007.02.001","volume":"46","author":"LA van Meeteren","year":"2007","unstructured":"van Meeteren, L. A., & Moolenaar, W. H. (2007). Regulation and biological activities of the autotaxin-LPA axis. Progress in Lipid Research, 46(2), 145\u201360. https:\/\/doi.org\/10.1016\/j.plipres.2007.02.001","journal-title":"Progress in Lipid Research"},{"issue":"4","key":"10759_CR31","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/hep.28973","volume":"65","author":"E Kaffe","year":"2017","unstructured":"Kaffe, E., Katsifa, A., Xylourgidis, N., Ninou, I., Zannikou, M., Harokopos, V., et al. (2017). Hepatocyte autotaxin expression promotes liver fibrosis and cancer. Hepatology, 65(4), 1369\u201383. https:\/\/doi.org\/10.1002\/hep.28973","journal-title":"Hepatology"},{"issue":"10","key":"10759_CR32","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1194\/jlr.M039685","volume":"54","author":"AK Salous","year":"2013","unstructured":"Salous, A. K., Panchatcharam, M., Sunkara, M., Mueller, P., Dong, A., Wang, Y., et al. (2013). Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. Journal of Lipid Research, 54(10), 2775\u201384. https:\/\/doi.org\/10.1194\/jlr.M039685","journal-title":"Journal of Lipid Research"},{"issue":"7","key":"10759_CR33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/CIRCRESAHA.116.303630","volume":"116","author":"TG Gillette","year":"2015","unstructured":"Gillette, T. G., & Hill, J. A. (2015). Readers, writers, and erasers: Chromatin as the whiteboard of heart disease. Circulation Research, 116(7), 1245\u20131253. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303630","journal-title":"Circulation Research"},{"key":"10759_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yjmcc.2018.04.011","volume":"119","author":"D Kimbrough","year":"2018","unstructured":"Kimbrough, D., Wang, S. H., Wright, L. H., Mani, S. K., Kasiganesan, H., LaRue, A. C., et al. (2018). HDAC inhibition helps post-MI healing by modulating macrophage polarization. Journal of Molecular and Cellular Cardiology, 119, 51\u201363. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.04.011","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"11","key":"10759_CR35","doi-asserted-by":"publisher","first-page":"H1391","DOI":"10.1152\/ajpheart.00390.2014","volume":"308","author":"SK Mani","year":"2015","unstructured":"Mani, S. K., Kern, C. B., Kimbrough, D., Addy, B., Kasiganesan, H., Rivers, W. T., et al. (2015). Inhibition of class I histone deacetylase activity represses matrix metalloproteinase-2 and -9 expression and preserves LV function postmyocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology, 308(11), H1391-401. https:\/\/doi.org\/10.1152\/ajpheart.00390.2014","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"10759_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.yjmcc.2017.12.004","volume":"114","author":"DJ Herr","year":"2018","unstructured":"Herr, D. J., Baarine, M., Aune, S. E., Li, X., Ball, L. E., Lemasters, J. J., et al. (2018). HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury. Journal of Molecular and Cellular Cardiology, 114, 309\u201319. https:\/\/doi.org\/10.1016\/j.yjmcc.2017.12.004","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10759_CR37","doi-asserted-by":"publisher","unstructured":"Wright, L. H., Herr, D. J., Brown, S. S., Kasiganesan, H., Menick, D. R. (2018). Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling. JCI Insight, 3(4). https:\/\/doi.org\/10.1172\/jci.insight.95824","DOI":"10.1172\/jci.insight.95824"},{"issue":"8","key":"10759_CR38","doi-asserted-by":"publisher","first-page":"e2304615","DOI":"10.1002\/adma.202304615","volume":"36","author":"RJ Bose","year":"2024","unstructured":"Bose, R. J., Kessinger, C. W., Dhammu, T., Singh, T., Shealy, M. W., Ha, K., et al. (2024). Biomimetic nanomaterials for the immunomodulation of the cardiosplenic axis postmyocardial infarction. Advanced Materials, 36(8), e2304615. https:\/\/doi.org\/10.1002\/adma.202304615","journal-title":"Advanced Materials"},{"issue":"42","key":"10759_CR39","doi-asserted-by":"publisher","first-page":"E2865","DOI":"10.1073\/pnas.1121131109","volume":"109","author":"X Chen","year":"2012","unstructured":"Chen, X., Barozzi, I., Termanini, A., Prosperini, E., Recchiuti, A., Dalli, J., et al. (2012). Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proceedings of the National Academy of Sciences, 109(42), E2865-74. https:\/\/doi.org\/10.1073\/pnas.1121131109","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"10759_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","volume":"6","author":"TM Maher","year":"2018","unstructured":"Maher, T. M., van der Aar, E. M., Van de Steen, O., Allamassey, L., Desrivot, J., Dupont, S., et al. (2018). Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): A phase 2a randomised placebo-controlled trial. The Lancet Respiratory Medicine, 6(8), 627\u201335. https:\/\/doi.org\/10.1016\/S2213-2600(18)30181-4","journal-title":"The Lancet Respiratory Medicine"},{"key":"10759_CR41","doi-asserted-by":"publisher","unstructured":"Corte, T. J., Lancaster, L., Swigris, J. J., Maher, T. M., Goldin, J. G., Palmer, S. M., et al. (2021). Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA(1)) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). BMJ Open Respiratory Research, 8(1). https:\/\/doi.org\/10.1136\/bmjresp-2021-001026","DOI":"10.1136\/bmjresp-2021-001026"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10759-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-024-10759-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10759-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T10:16:16Z","timestamp":1727777776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-024-10759-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10759"],"URL":"https:\/\/doi.org\/10.1007\/s12015-024-10759-7","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"26 June 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were carried out according to the NIH Guidelines on the Use of Laboratory Animals and the guidelines of the Animal Care and Use Committee of the University of Kentucky, Lexington, KY. All animal procedures were approved by the University of Kentucky Institutional Animal Care and Use Committee (IACUC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable, as this study did not involve human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable, as this study did not involve human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The authors declare that they have no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}